This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2001 Nov 1;19(21):4093-6.

doi: 10.1200/JCO.2001.19.21.4093.

Oral versus intravenous fluoropyrimidines for advanced colorectal cancer: by either route, it's all the same

PMID: 11689576
DOI: 10.1200/JCO.2001.19.21.4093

Review

Oral versus intravenous fluoropyrimidines for advanced colorectal cancer: by either route, it's all the same

R J Mayer. J Clin Oncol. 2001.

. 2001 Nov 1;19(21):4093-6.

doi: 10.1200/JCO.2001.19.21.4093.

Author

PMID: 11689576
DOI: 10.1200/JCO.2001.19.21.4093

No abstract available

PubMed Disclaimer

Comment on

Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study.
Van Cutsem E, Twelves C, Cassidy J, Allman D, Bajetta E, Boyer M, Bugat R, Findlay M, Frings S, Jahn M, McKendrick J, Osterwalder B, Perez-Manga G, Rosso R, Rougier P, Schmiegel WH, Seitz JF, Thompson P, Vieitez JM, Weitzel C, Harper P; Xeloda Colorectal Cancer Study Group. Van Cutsem E, et al. J Clin Oncol. 2001 Nov 1;19(21):4097-106. doi: 10.1200/JCO.2001.19.21.4097. J Clin Oncol. 2001. PMID: 11689577 Clinical Trial.

Similar articles

First-line capecitabine is as effective as 5-fluorouracil/leucovorin in treating advanced colorectal cancer.
Gambill BD. Gambill BD. Clin Colorectal Cancer. 2001 May;1(1):18-9. doi: 10.1016/S1533-0028(11)70533-3. Clin Colorectal Cancer. 2001. PMID: 12445375 No abstract available.
[Oral fluoropyrimidines in the treatment of colorectal carcinoma].
Porschen R. Porschen R. Dtsch Med Wochenschr. 2003 Jun 13;128 Suppl 2:S121-3. doi: 10.1055/s-2003-40145. Dtsch Med Wochenschr. 2003. PMID: 12817344 Review. German. No abstract available.
On prejudice and facts and choices.
Köhne CH, Folprecht G. Köhne CH, et al. Ann Oncol. 2006 Feb;17(2):185-7. doi: 10.1093/annonc/mdj142. Ann Oncol. 2006. PMID: 16428244 No abstract available.
Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study.
Van Cutsem E, Twelves C, Cassidy J, Allman D, Bajetta E, Boyer M, Bugat R, Findlay M, Frings S, Jahn M, McKendrick J, Osterwalder B, Perez-Manga G, Rosso R, Rougier P, Schmiegel WH, Seitz JF, Thompson P, Vieitez JM, Weitzel C, Harper P; Xeloda Colorectal Cancer Study Group. Van Cutsem E, et al. J Clin Oncol. 2001 Nov 1;19(21):4097-106. doi: 10.1200/JCO.2001.19.21.4097. J Clin Oncol. 2001. PMID: 11689577 Clinical Trial.
Capecitabine: fulfilling the promise of oral chemotherapy.
Hwang JJ, Marshall JL. Hwang JJ, et al. Expert Opin Pharmacother. 2002 Jun;3(6):733-43. doi: 10.1517/14656566.3.6.733. Expert Opin Pharmacother. 2002. PMID: 12036413 Review.

See all similar articles

Cited by

Risk and management of venous thromboembolisms in bevacizumab-treated metastatic colorectal cancer patients.
Yu I, Chen L, Ruan JY, Chang JT, Cheung WY. Yu I, et al. Support Care Cancer. 2016 Mar;24(3):1199-208. doi: 10.1007/s00520-015-2899-y. Epub 2015 Aug 19. Support Care Cancer. 2016. PMID: 26286113
XELIRI compared with FOLFIRI as a second-line treatment in patients with metastatic colorectal cancer.
Cui C, Shu C, Yang Y, Liu J, Shi S, Shao Z, Wang N, Yang T, Hu S. Cui C, et al. Oncol Lett. 2014 Oct;8(4):1864-1872. doi: 10.3892/ol.2014.2335. Epub 2014 Jul 10. Oncol Lett. 2014. PMID: 25202427 Free PMC article.
Management of a locally advanced rectal cancer in a patient who declined surgery.
Alameddine R, Wehbe D, Weiser M, Segal N, Goodman K, Shamseddine A, Ang C, Haydar A, Sidani M, Geara F, Naghy M, O'Reilly EM, Abou-Alfa GK. Alameddine R, et al. Gastrointest Cancer Res. 2012 Nov;5(6):205-9. Gastrointest Cancer Res. 2012. PMID: 23293703 Free PMC article. No abstract available.
Phase II study of UFT and oxaliplatin in first-line treatment of advanced colorectal cancer.
Feliu J, Vicent JM, García-Girón C, Constela M, Fonseca E, Aparicio J, Lomas M, Antón-Aparicio L, Dorta FJ, Gonzalez-Baron M; Oncopaz Cooperative Group and Associated Hospitals. Feliu J, et al. Br J Cancer. 2004 Nov 15;91(10):1758-62. doi: 10.1038/sj.bjc.6602217. Br J Cancer. 2004. PMID: 15505621 Free PMC article. Clinical Trial.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information